Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

The main purpose of the study is to evaluate the efficacy and safety of ecnoglutide injections versus placebo in obese participants with KOA.

Participants needed: 360
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Sciwind Biosciences Co., Ltd.Updated: Jul 29, 2026Locations: 1
Eligibility criteria

Body mass index (BMI) ≥ 28.0 kg/m²; [+4]

The target knee has undergone joint replacement surgery; [+12]

Read more
Status: Recruiting

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA receiving PAP

Participants needed: 140
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Sciwind Biosciences Co., Ltd.Updated: Apr 13, 2026Locations: 1
Eligibility criteria

Body mass index (BMI) ≥ 28.0 kg/m2; [+3]

History of endocrine disorders which have significant impact on body weight; [+9]

Read more
Status: Recruiting

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP

Participants needed: 140
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Sciwind Biosciences Co., Ltd.Updated: Apr 14, 2026Locations: 1
Eligibility criteria

Body mass index (BMI) ≥ 28.0 kg/m2; [+3]

History of endocrine disorders which have significant impact on body weight; [+9]

Read more
Status: Recruiting

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral ecnoglutide tablets in Chinese participants with overweight or obesity

Participants needed: 84
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Hangzhou Sciwind Biosciences Co., Ltd.Updated: Jan 28, 2026Locations: 1
Eligibility criteria

At the time of informed consent, with BMI in the range of 24.0 to 35.0 kg/m2 (in... [+1]

Diagnosis of overweight or obesity due to endocrine disorders , such as Cushing'... [+6]

Read more